Literature DB >> 1371410

Treatment of hairy cell leukemia.

A Saven1, L D Piro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1371410

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.

Authors:  Hagop Kantarjian; Susan O'Brien; Jorge Cortes; William Wierda; Stefan Faderl; Guillermo Garcia-Manero; Jean-Pierre Issa; Elihu Estey; Michael Keating; Emil J Freireich
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Phase II clinical study of cladribine in the treatment of hairy cell leukemia.

Authors:  Takashi Machii; Takaaki Chou; Muneou Suzuki; Yokiko Ohe; Shuichi Katagiri; E Kiyoshi Kitano; Kiyoshi Kitano; Yoshihide Fujiyama; Tooru Izumi; Chihiro Shimazaki; Koji Nanba; Yasuo Ohashi; Teruo Kitani
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

3.  Diagnostic relevance of peripheral blood immunocytochemistry in hairy cell leukaemia.

Authors:  I Cordone; L Annino; S Masi; E Pescarmona; S Rahimi; A Ferrari; E Giubilei; P Pignoloni; T Faraggiana; F Mandelli
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

Review 4.  The optimal management of hairy cell leukaemia.

Authors:  R Gollard; T C Lee; L D Piro; A Saven
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

5.  Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro.

Authors:  B Barut; D Chauhan; H Uchiyama; K C Anderson
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 6.  Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

7.  Postoperative complications after splenectomy for hematologic malignancies.

Authors:  J Horowitz; J L Smith; T K Weber; M A Rodriguez-Bigas; N J Petrelli
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

Review 8.  Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?

Authors:  Mukundan Baskar Mannargudi; Subrata Deb
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-17       Impact factor: 4.322

9.  Hairy cell leukemia treatment: where we are now?

Authors:  Svetlana Krstevska; Sonja Genadieva-Stavric; Tatjana Sotirova; Dejan Spasovski; Trajan Balkanov
Journal:  Mater Sociomed       Date:  2011

Review 10.  Human interferon alpha-2b: a therapeutic protein for cancer treatment.

Authors:  Ratih Asmana Ningrum
Journal:  Scientifica (Cairo)       Date:  2014-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.